Treating atherosclerosis: targeting risk factors should not be the only option
- PMID: 30613609
- PMCID: PMC6291595
- DOI: 10.21037/atm.2018.09.40
Treating atherosclerosis: targeting risk factors should not be the only option
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Figures

Comment on
-
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.EBioMedicine. 2018 Feb;28:225-233. doi: 10.1016/j.ebiom.2017.12.021. Epub 2017 Dec 20. EBioMedicine. 2018. PMID: 29361501 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources